VRTX Insider Transactions — Page 11
3,822 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1,001–1,100; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Lee Yuchun | Director | 2020-04-22 | Sale | 300.0 | $269.47 |
| Lee Yuchun | Director | 2020-04-22 | Sale | 224.0 | $268.48 |
| Lee Yuchun | Director | 2020-04-22 | Sale | 507.0 | $267.34 |
| Lee Yuchun | Director | 2020-04-22 | Sale | 300.0 | $266.18 |
| Lee Yuchun | Director | 2020-04-22 | Sale | 300.0 | $265.16 |
| Lee Yuchun | Director | 2020-04-21 | Sale | 100.0 | $272.63 |
| Lee Yuchun | Director | 2020-04-21 | Sale | 300.0 | $271.38 |
| Lee Yuchun | Director | 2020-04-21 | Sale | 100.0 | $268.5 |
| Lee Yuchun | Director | 2020-04-21 | Sale | 403.0 | $267.15 |
| Lee Yuchun | Director | 2020-04-21 | Sale | 300.0 | $265.88 |
| Lee Yuchun | Director | 2020-04-21 | Sale | 500.0 | $264.8 |
| Lee Yuchun | Director | 2020-04-21 | Sale | 297.0 | $263.2 |
| Lee Yuchun | Director | 2020-04-20 | Sale | 500.0 | $274.65 |
| Lee Yuchun | Director | 2020-04-20 | Sale | 890.0 | $273.61 |
| Lee Yuchun | Director | 2020-04-20 | Sale | 510.0 | $271.52 |
| Lee Yuchun | Director | 2020-04-20 | Sale | 100.0 | $269.97 |
| Silva Paul M | SVP & Controller | 2020-04-13 | Sale | 166.0 | $252.26 |
| Silva Paul M | SVP & Controller | 2020-04-13 | Sale | 193.0 | $250.29 |
| Silva Paul M | SVP & Controller | 2020-04-13 | Sale | 150.0 | $248.96 |
| Silva Paul M | SVP & Controller | 2020-04-13 | Sale | 150.0 | $247.18 |
| Silva Paul M | SVP & Controller | 2020-04-13 | Sale | 150.0 | $245.62 |
| Silva Paul M | SVP & Controller | 2020-04-13 | Sale | 50.0 | $244.09 |
| Silva Paul M | SVP & Controller | 2020-04-06 | Sale | 4,891.0 | $255.57 |
| Tatsis Ourania | SVP, CRO | 2020-02-25 | Sale | 240.0 | $237.81 |
| Tatsis Ourania | SVP, CRO | 2020-02-25 | Sale | 160.0 | $235.39 |
| Tatsis Ourania | SVP, CRO | 2020-02-25 | Sale | 240.0 | $234.43 |
| Tatsis Ourania | SVP, CRO | 2020-02-25 | Sale | 80.0 | $232.43 |
| Tatsis Ourania | SVP, CRO | 2020-02-25 | Sale | 160.0 | $231.82 |
| Tatsis Ourania | SVP, CRO | 2020-02-25 | Sale | 416.0 | $229.57 |
| Silva Paul M | SVP & Controller | 2020-02-25 | Sale | 150.0 | $238.4 |
| Silva Paul M | SVP & Controller | 2020-02-25 | Sale | 90.0 | $236.85 |
| Silva Paul M | SVP & Controller | 2020-02-25 | Sale | 150.0 | $235.49 |
| Silva Paul M | SVP & Controller | 2020-02-25 | Sale | 150.0 | $234.5 |
| Silva Paul M | SVP & Controller | 2020-02-25 | Sale | 120.0 | $232.4 |
| Silva Paul M | SVP & Controller | 2020-02-25 | Sale | 137.0 | $231.17 |
| Silva Paul M | SVP & Controller | 2020-02-25 | Sale | 283.0 | $229.66 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-25 | Sale | 540.0 | $238.33 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-25 | Sale | 180.0 | $236.63 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-25 | Sale | 360.0 | $235.75 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-25 | Sale | 533.0 | $234.56 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-25 | Sale | 90.0 | $233.18 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-25 | Sale | 450.0 | $232.62 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-25 | Sale | 270.0 | $230.98 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-25 | Sale | 953.0 | $230.0 |
| Parini Michael | EVP, CL&AO | 2020-02-25 | Sale | 480.0 | $238.3 |
| Parini Michael | EVP, CL&AO | 2020-02-25 | Sale | 320.0 | $236.26 |
| Parini Michael | EVP, CL&AO | 2020-02-25 | Sale | 640.0 | $234.77 |
| Parini Michael | EVP, CL&AO | 2020-02-25 | Sale | 320.0 | $232.89 |
| Parini Michael | EVP, CL&AO | 2020-02-25 | Sale | 330.0 | $231.62 |
| Parini Michael | EVP, CL&AO | 2020-02-25 | Sale | 938.0 | $230.07 |
| LEIDEN JEFFREY M | CEO & President | 2020-02-25 | Sale | 1,680.0 | $238.33 |
| LEIDEN JEFFREY M | CEO & President | 2020-02-25 | Sale | 560.0 | $236.63 |
| LEIDEN JEFFREY M | CEO & President | 2020-02-25 | Sale | 1,210.0 | $235.53 |
| LEIDEN JEFFREY M | CEO & President | 2020-02-25 | Sale | 1,640.0 | $234.49 |
| LEIDEN JEFFREY M | CEO & President | 2020-02-25 | Sale | 1,017.0 | $232.96 |
| LEIDEN JEFFREY M | CEO & President | 2020-02-25 | Sale | 1,050.0 | $231.76 |
| LEIDEN JEFFREY M | CEO & President | 2020-02-25 | Sale | 1,120.0 | $230.4 |
| LEIDEN JEFFREY M | CEO & President | 2020-02-25 | Sale | 2,273.0 | $229.77 |
| Kewalramani Reshma | EVP and CMO | 2020-02-25 | Sale | 111.0 | $239.13 |
| Kewalramani Reshma | EVP and CMO | 2020-02-25 | Sale | 420.0 | $238.28 |
| Kewalramani Reshma | EVP and CMO | 2020-02-25 | Sale | 320.0 | $236.71 |
| Kewalramani Reshma | EVP and CMO | 2020-02-25 | Sale | 340.0 | $235.36 |
| Kewalramani Reshma | EVP and CMO | 2020-02-25 | Sale | 660.0 | $234.41 |
| Kewalramani Reshma | EVP and CMO | 2020-02-25 | Sale | 440.0 | $232.35 |
| Kewalramani Reshma | EVP and CMO | 2020-02-25 | Sale | 450.0 | $230.88 |
| Kewalramani Reshma | EVP and CMO | 2020-02-25 | Sale | 893.0 | $229.72 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | 2020-02-25 | Sale | 632.0 | $238.33 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | 2020-02-25 | Sale | 20.0 | $236.88 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | 2020-02-25 | Sale | 420.0 | $236.36 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | 2020-02-25 | Sale | 540.0 | $235.14 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | 2020-02-25 | Sale | 420.0 | $234.08 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | 2020-02-25 | Sale | 360.0 | $232.35 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | 2020-02-25 | Sale | 432.0 | $230.85 |
| Arbuckle Stuart A | EVP, Chief Commercial Officer | 2020-02-25 | Sale | 810.0 | $229.78 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2020-02-25 | Sale | 480.0 | $238.33 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2020-02-25 | Sale | 160.0 | $236.8 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2020-02-25 | Sale | 280.0 | $235.53 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2020-02-25 | Sale | 574.0 | $234.52 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2020-02-25 | Sale | 400.0 | $232.51 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2020-02-25 | Sale | 400.0 | $230.77 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2020-02-25 | Sale | 734.0 | $229.72 |
| Tatsis Ourania | SVP, CRO | 2020-02-18 | Sale | 145.0 | $245.75 |
| Tatsis Ourania | SVP, CRO | 2020-02-18 | Sale | 286.0 | $244.99 |
| Tatsis Ourania | SVP, CRO | 2020-02-18 | Sale | 160.0 | $243.78 |
| Tatsis Ourania | SVP, CRO | 2020-02-18 | Sale | 528.0 | $242.78 |
| Tatsis Ourania | SVP, CRO | 2020-02-18 | Sale | 160.0 | $241.82 |
| Silva Paul M | SVP & Controller | 2020-02-18 | Sale | 202.0 | $245.74 |
| Silva Paul M | SVP & Controller | 2020-02-18 | Sale | 280.0 | $245.0 |
| Silva Paul M | SVP & Controller | 2020-02-18 | Sale | 202.0 | $243.85 |
| Silva Paul M | SVP & Controller | 2020-02-18 | Sale | 640.0 | $242.8 |
| Silva Paul M | SVP & Controller | 2020-02-18 | Sale | 240.0 | $241.95 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-18 | Sale | 249.0 | $245.82 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-18 | Sale | 720.0 | $245.15 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-18 | Sale | 540.0 | $244.08 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-18 | Sale | 1,260.0 | $242.85 |
| Sachdev Amit | EVP, Chief Patient Officer | 2020-02-18 | Sale | 720.0 | $242.04 |
| Parini Michael | EVP, CL&AO | 2020-02-18 | Sale | 694.0 | $245.52 |
| Parini Michael | EVP, CL&AO | 2020-02-18 | Sale | 416.0 | $244.64 |
| Parini Michael | EVP, CL&AO | 2020-02-18 | Sale | 560.0 | $243.59 |
| Parini Michael | EVP, CL&AO | 2020-02-18 | Sale | 1,098.0 | $242.64 |